 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- ||||| live influenza vaccine (freeze-dried) / Changchun BCHT Biotechnology
New P2 trial: The Safety and Immunogenicity Evaluation of Live Attenuated Influenza Vaccine (clinicaltrials.gov) - Mar 16, 2022
P2, N=2520, Not yet recruiting, Sponsor: Changchun BCHT Biotechnology Co.
- ||| live influenza vaccine (freeze-dried) / Changchun BCHT Biotechnology
New P1 trial: The Safety and Immunogenicity Evaluation of Live Attenuated Influenza Vaccine (clinicaltrials.gov) - Sep 23, 2021
P1, N=160, Recruiting, Sponsor: Changchun BCHT Biotechnology Co.